As a dedicated psychedelics manufacturer, Psygen has harnessed more than 50 years of combined experience synthesizing psychedelics to provide a catalogue of GMP APIs for clinicians, researchers, and drug developers.
Psygen’s mission is to bring meaning back to life by improving access to psychedelics.
Psygen’s State-of-the-art facility
Psygen’s 17,000 sq. ft. facility will be GMP-compliant and enable large-scale synthesis of psychedelic compounds in a production area of 6,000 sq. ft.
Psygen has received a Health Canada dealer’s license which allows the manufacture, sale, import, export, and analysis of LSD, 2C-B, DMT, MDMA, psilocybin, and mescaline.